Skip to main content
Log in

High production of SPARC/osteonectin/BM-40 in mouse metastatic B16 melanoma cell lines

  • Article
  • Published:
Pathology Oncology Research

Abstract

Production of SPARC/osteonectin/BM-40 was determined in mouse B16 melanoma clones BL6 and F10 (high metastatic) and Fl (low metastatic). SPARC was produced greater amount in BL6 and F10 than in Fl cells, showing a good agreement with their metastatic potentials. Moreover, SPARC production was not influenced by culture pH, even in the acidic conditions (≈pH 5.9). Although tumor tissues show often low pH due to excessive amount of acidic metabolites such as lactate, most studies have been done in neutral pH. High SPARC production in the acidic medium, therefore, is thought to be an important potential for tumor invasive behaviour.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Termine JD, Kleinman HK, Whitson SW et al: Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26:99–105, 1981.

    Article  PubMed  CAS  Google Scholar 

  2. Mason IJ, Taylor A, Williams JG, et al: Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell ‘culture shock’ glycoprotein of Mr 43,000. EMBO J 5:1465–1472, 1986.

    PubMed  CAS  Google Scholar 

  3. Mann K, Deutzmann R, Paulsson M, Timpl R: Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC. FEBS Lett 218:167–172, 1987.

    Article  PubMed  CAS  Google Scholar 

  4. Bellahcene A, Castronovo V: Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 146:95–100, 1995.

    PubMed  CAS  Google Scholar 

  5. Porte H, Chastre E, Prevot S, et al: Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer 64:70–75, 1995.

    Article  PubMed  CAS  Google Scholar 

  6. Porte H, Triboulet JP, Kotelevets L, et al: Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. Clin Cancer Res 4:1375–1382, 1998.

    PubMed  CAS  Google Scholar 

  7. Ledda F, Bravo AI, Adris S, et al. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol 108:210–214, 1997.

    Article  PubMed  CAS  Google Scholar 

  8. Massi D, Franchi A, Borgognoni L, et al: Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas. Hum Pathol 30:339–344, 1999.

    Article  PubMed  CAS  Google Scholar 

  9. Rempel SA, Golembieski M, Ge S, et al: SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J Neuropathol Exp Neurol 57:1112–1121, 1998.

    Article  PubMed  CAS  Google Scholar 

  10. Rempel SA, Ge S, Gutierrez JA: SPARC: a potential diagnostic marker of invasive meningiomas. Clin Cancer Res 5:237–241, 1999.

    PubMed  CAS  Google Scholar 

  11. Le Bail B, Faouzi S, Boussarie L, et al: Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol 189:46–52, 1999.

    Article  PubMed  Google Scholar 

  12. Ledda MF, Adris S, Bravo AI, et al: Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nature Med 3:171–176, 1997.

    Article  PubMed  CAS  Google Scholar 

  13. Tremble PM, Lane TF, Sage EH, Werb Z: SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 121:1433–1444, 1993.

    Article  PubMed  CAS  Google Scholar 

  14. Shankavaram UT, De Witt DL, Funk SE, et al: Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 173:327–334, 1997.

    Article  PubMed  CAS  Google Scholar 

  15. Gilles C, Bassuk JA, Pulyaeva H, et al: SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res 58:5529–5536, 1998.

    PubMed  CAS  Google Scholar 

  16. Kato Y, Sakai N, Baba M, et al: Stimulation of motility of human renal cell carcinoma by SPARC/osteonectin/BM-40 associated with type IV collagen. Invasion Metastasis 18:105–114, 1999.

    Article  CAS  Google Scholar 

  17. Jacob K, Webber M, Benayahu D, Kleinman HK: Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res 59:4453–4457, 1999.

    PubMed  CAS  Google Scholar 

  18. Kato Y, Nakayama Y, Umeda M, Miyazaki K: Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J Biol Chem 267:11424–11430, 1992.

    PubMed  CAS  Google Scholar 

  19. Kato Y, Ozono S, Shuin T, Miyazaki K: Slow induction of gelatinase B mRNA by acidic culture conditions in mouse metastatic melanoma cells. Cell Biol Int 20:375–377, 1996.

    Article  PubMed  CAS  Google Scholar 

  20. Martinez-Zaguilán R, Seftor EA, Seftor RE, et al: Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 14:176–186, 1996.

    Article  PubMed  Google Scholar 

  21. Sasaki T, Gohring W, Mann K, et al: Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem 272:9237–9243, 1997.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasumasa Kato.

Additional information

This work was supported by Public Trust Haraguchi Memorial Cancer Research Found, Japan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kato, Y., Frankenne, F., Noël, A. et al. High production of SPARC/osteonectin/BM-40 in mouse metastatic B16 melanoma cell lines. Pathol. Oncol. Res. 6, 24–26 (2000). https://doi.org/10.1007/BF03032654

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03032654

Keywords

Navigation